Two important events happened in the ASPREE Healthy Ageing Biobank this week. Opening of a new storage facility for...
Researchers
Aspirin, DNA and Cancer: ASPREE comment on JAMA paper
A recent report that an individual’s genetic make-up could determine whether aspirin had a positive or negative effect...
2014. What a Year!
A summary of highlights for the ASPREE trial as recruitment phase ends Thanks to the wonderful support from...
ASPREE Investigator interview on Radio National Health Report
A recap on aspirin and primary prevention aspirin trials Professor Mark Nelson, Chief Investigator to the...
World-first Aspirin Trial Reaches Target
Announcement Melbourne, December 1, 2014 – Australia’s largest clinical trial is a step closer to revealing in...
Aspirin and Cancer Symposium draws leading researchers
Possible mechanisms of aspirin discussed ANNOUNCEMENT Melbourne, 20 October 2014: The use of aspirin to...
Researcher showcases her community
Wonthaggi's support for Medical Research Dr Sharyn Fitzgerald, ASPREE Regional Manager, visited her home town...
Aspirin May Reduce Cancer Risk in Middle-Aged; Benefit in Older People Unknown
Lack of data underscores importance of ASPREE trial A large scientific review revealed that aspirin protected people...
ASPREE in 2013 – what a year!!
A run-down of an amazing year for the ASPREE Clinical Trial In 2013, we reached a number of significant...
ASPREE trial launched in Wollongong
ANNOUNCEMENT Wollongong locals to participate in Australia’s largest primary prevention Aspirin trial Above:...